Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Stuttgart - Delayed Quote • EUR Cellectis SA (ZVA.SG) Follow Compare 1.0420 -0.1300 (-11.09%) At close: 8:09:51 AM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for ZVA.SG 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: ZVA.SG View More All News Press Releases SEC Filings Monthly information on share capital and company voting rights Discover European Penny Stocks: I.M.D. International Medical Devices And 2 More To Watch Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025 Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025 Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer Do Options Traders Know Something About Cellectis (CLLS) Stock We Don't? Analysts Predict 400% Upside Potential for This Penny Stock Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB) Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting Cellectis Provides Business Updates and Financial Results for Third Quarter 2024 Related Tickers CYAD.BR Celyad Oncology SA 0.4830 +2.77% KYTX Kyverna Therapeutics, Inc. 2.0600 +10.16% ADAP Adaptimmune Therapeutics plc 0.2223 +3.40% ALLO Allogene Therapeutics, Inc. 1.4500 +5.84%